PA
GRSD

PharVision Advisers’s Grandstand Limited Ordinary Shares GRSD Stock Holding History

PharVision Advisers’s Portfolio GRSD Stock Details GRSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,609
Closed -$544K – 359
2024
Q4 		$544K Buy
+38,609
New +$454K 0.46% 29

Other funds holding GRSD

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PharVision Advisers's GRSD Position: Q1 2025 in Review

PharVision Advisers sold out of Grandstand Limited Ordinary Shares (GRSD) in Q1 2025, closing a stake of 38,609 shares — an estimated $544K sold.

PharVision Advisers first reported a position in GRSD in Q4 2024 and held it in 1 quarter. The position peaked at $544K in Q4 2024. 141 funds tracked by Wall St. Rank hold GRSD as of Q1 2025.

  • PharVision Advisers reported no remaining Grandstand Limited Ordinary Shares position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 38,609 Grandstand Limited Ordinary Shares shares in Q1 2025, an estimated $544K.
  • PharVision Advisers first reported a position in Grandstand Limited Ordinary Shares in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Grandstand Limited Ordinary Shares position peaked at $544K in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Grandstand Limited Ordinary Shares as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.